ro-23-7553
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Vitamin D receptorAGONIST
VDR agonist
Chemistry & pharmacology
Loading structure…
SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O- Mol. weight
- 410.6 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL284121 ↗
Also known as
- 1,25-dihydroxy-16-ene-23-yne-vitamin d3
- 1,25-dihydroxy-delta(16)-23-yne-vitamin d3
- 1,25-(oh)2-16ene-23yne-d3
- 1,25(oh)2-16-ene-23-yne-d3
- 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin d(3)
- 1alpha,25-dihydroxy-16ene, 23yne-vitamin d3
- bxl-353
- bxl-353
- holly
- ilex
- ilex
- ilx23-7553
- ilx23-7553
- ilx-7553
- ilx-7553
- ro 23-7553
- ro-23-7553
- ro-23-7553
- ro-23-7553
- ro 23-7553, (3beta,5z,7e)-isomer